Literature DB >> 22233523

Pricing human papillomavirus vaccines: lessons from Italy.

Livio Garattini1, Katelijne van de Vooren, Alessandro Curto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22233523     DOI： 10.2165/11596560-000000000-00000

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  8 in total

1.  The current state of introduction of human papillomavirus vaccination into national immunisation schedules in Europe: first results of the VENICE2 2010 survey.

Authors:  F Dorleans; C Giambi; L Dematte; S Cotter; P Stefanoff; J Mereckiene; D O'Flanagan; P L Lopalco; F D'Ancona; D Levy-Bruhl
Journal:  Euro Surveill       Date:  2010-11-25

2.  The evolution of health-policy making in Italy.

Authors:  George France; Francesco Taroni
Journal:  J Health Polit Policy Law       Date:  2005 Feb-Apr       Impact factor: 2.265

3.  Cervical cancer screening policies and coverage in Europe.

Authors:  Ahti Anttila; Lawrence von Karsa; Auni Aasmaa; Muriel Fender; Julietta Patnick; Matejka Rebolj; Florian Nicula; Laszlo Vass; Zdravka Valerianova; Lydia Voti; Catherine Sauvaget; Guglielmo Ronco
Journal:  Eur J Cancer       Date:  2009-08-19       Impact factor: 9.162

4.  Global HPV vaccination.

Authors:  Sophie Arie
Journal:  BMJ       Date:  2011-02-16

5.  Management of vaccinations in Italy: a national survey after healthcare regionalization.

Authors:  Livio Garattini; Anna Padula; Gianluigi Casadei
Journal:  J Med Econ       Date:  2011-07-07       Impact factor: 2.448

Review 6.  Cost-effectiveness analyses of human papillomavirus vaccination.

Authors:  Anthony T Newall; Philippe Beutels; James G Wood; W John Edmunds; C Raina MacIntyre
Journal:  Lancet Infect Dis       Date:  2007-04       Impact factor: 25.071

Review 7.  Human papillomavirus and cervical cancer.

Authors:  Mark Schiffman; Philip E Castle; Jose Jeronimo; Ana C Rodriguez; Sholom Wacholder
Journal:  Lancet       Date:  2007-09-08       Impact factor: 79.321

8.  Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.

Authors:  Suzanne M Garland; Mauricio Hernandez-Avila; Cosette M Wheeler; Gonzalo Perez; Diane M Harper; Sepp Leodolter; Grace W K Tang; Daron G Ferris; Marc Steben; Janine Bryan; Frank J Taddeo; Radha Railkar; Mark T Esser; Heather L Sings; Micki Nelson; John Boslego; Carlos Sattler; Eliav Barr; Laura A Koutsky
Journal:  N Engl J Med       Date:  2007-05-10       Impact factor: 91.245
  8 in total
  9 in total

1.  Human papillomavirus vaccination is not exclusively a matter of price.

Authors:  Alessandro Capone; Giampiero Favato
Journal:  Pharmacoeconomics       Date:  2012-05       Impact factor: 4.981

Review 2.  Economic Evidence of Pneumococcal Vaccination in Older Adults: Uncertain Modelling or Competitive Tendering?

Authors:  Livio Garattini; Anna Padula; Milene Rangel Da Costa
Journal:  Pharmacoeconomics       Date:  2016-03       Impact factor: 4.981

3.  Tendering and value-based pricing: lessons from Italy on human papilloma virus vaccines.

Authors:  Livio Garattini; Katelijne Van de Vooren; Nick Freemantle
Journal:  J R Soc Med       Date:  2014-01       Impact factor: 5.344

Review 4.  A critical review of cost-effectiveness analyses of vaccinating males against human papillomavirus.

Authors:  Yiling Jiang; Aline Gauthier; Maarten J Postma; Laureen Ribassin-Majed; Nathalie Largeron; Xavier Bresse
Journal:  Hum Vaccin Immunother       Date:  2013-07-23       Impact factor: 3.452

Review 5.  Cost effectiveness of the new pneumococcal vaccines: a systematic review of European studies.

Authors:  Katelijne van de Vooren; Silvy Duranti; Alessandro Curto; Livio Garattini
Journal:  Pharmacoeconomics       Date:  2014-01       Impact factor: 4.981

6.  Pricing of HPV vaccines in European tender-based settings.

Authors:  Venetia Qendri; Johannes A Bogaards; Johannes Berkhof
Journal:  Eur J Health Econ       Date:  2018-07-26

Review 7.  Vaccine Prices: A Systematic Review of Literature.

Authors:  Rabia Hussain; Nadeem Irfan Bukhari; Anees Ur Rehman; Mohamed Azmi Hassali; Zaheer-Ud-Din Babar
Journal:  Vaccines (Basel)       Date:  2020-10-29

8.  Transparency or proper study valuation procedures missed?

Authors:  Giampiero Favato; Gianluca Baio; Alessandro Capone; Andrea Marcellusi; Silvano Costa; Giorgia Garganese; Mauro Picardo; Mike Drummond; Bengt Jonsson; Giovanni Scambia; Peter Zweifel; Francesco S Mennini
Journal:  Med Care       Date:  2013-04       Impact factor: 2.983

9.  The Bayesian model on human papillomavirus vaccination in Italy lacks transparency.

Authors:  Livio Garattini; Katelijne van de Vooren
Journal:  Med Care       Date:  2013-04       Impact factor: 2.983
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.